{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T11:57:15Z","timestamp":1715169435907},"reference-count":16,"publisher":"EDP Sciences","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1051\/medsci\/20062210881","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T11:39:20Z","timestamp":1299325160000},"page":"881-886","source":"Crossref","is-referenced-by-count":1,"title":["Diff\u00e9rences et similitudes des promotions industrielles et des promotions institutionnelles"],"prefix":"10.1051","volume":"22","author":[{"given":"Jo\u00ebl","family":"M\u00e9nard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Daurat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2006,10,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Grimes DA, Hubacher D, Nanda K,et al.The good clinical practice guideline : a bronze standard for clinical research.Lancet2005; 366 : 172\u20134.","DOI":"10.1016\/S0140-6736(05)66875-4"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Lievre M, Menard J, Bruckert E,et al.Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.Br Med J2001; 322 : 603\u20135.","DOI":"10.1136\/bmj.322.7286.603"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Psaty BM, Rennie D. Stopping medical research to save money : a broken pact with researchers and patients.JAMA2003; 289 : 2128\u201331.","DOI":"10.1001\/jama.289.16.2128"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Bombardier C, Laine L, Reicin A,et al.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. Vigor study group.N Engl J Med2000; 343 : 1520\u20138.","DOI":"10.1056\/NEJM200011233432103"},{"key":"R5","unstructured":"Silverstein F, Simon L, Faich G. Reporting of 6-monthversus12-month data in a clinical trial of Celocoxib.JAMA2001; 286 : 2398\u2013400."},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Steinbrook R. Protecting research subjects : the crisis at Johns Hopkins.N Engl J Med2002; 346 : 716\u201320.","DOI":"10.1056\/NEJM200202283460924"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Ray WA, Stein CM. Reform of drug regulation--beyond an independent drug-safety board.N Engl J Med2006; 354 : 194\u2013201.","DOI":"10.1056\/NEJMsb053432"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Brun-Buisson C. Les DSMB. 1. Quel r\u00f4le, quelles responsabilit\u00e9s ?Med Sci (Paris)2005; 21 : 78\u201382.","DOI":"10.1051\/medsci\/200521178"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Brun-Buisson C. Les DSMB. 2.De l\u2019importance d\u2019un DSMB efficace, exemples d\u2019essais cliniques \u00e0 risque.Med Sci (Paris)2005; 21 : 187\u20139.","DOI":"10.1051\/medsci\/2005212187"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Ioannidis JP. Why most published research findings are false.PLoS Med2005; 2 : e124.","DOI":"10.1371\/journal.pmed.0020124"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Hampton T. Biomedical journals probe peer review.JAMA2005; 294 : 2287\u20138.","DOI":"10.1001\/jama.294.18.2287"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.Lancet1984; 1 : 1311\u20135.","DOI":"10.1016\/S0140-6736(84)91816-6"},{"key":"R13","unstructured":"Angell M.The truth about the drug companies. New York : Random House, 2004."},{"key":"R14","unstructured":"Daurat V. Les r\u00e8gles de l\u2019AP-HP promoteur.Journal de la DRRC de l\u2019Ile-de-France2002; 1 : 3.2."},{"key":"R15","unstructured":"Daurat V. Les r\u00e8gles de l\u2019AP-HP promoteur.Lettre de la DRRC de l\u2019Ile-de-France2002; 2 : 3.3.1."},{"key":"R16","unstructured":"M\u00e9nard J. Qui a tu\u00e9 Ellen Roche ?Lettre de la DRRC de l\u2019Ile-de-France2002; 2 : 3.2."}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20062210881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T01:05:36Z","timestamp":1560042336000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20062210881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":16,"journal-issue":{"issue":"10"},"alternative-id":["medsci20062210p881"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/20062210881","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}